These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1990569)

  • 1. Recombinant erythropoietin: does it really effect sensitization?
    Phelan DL; Hibbett S; Wetter L; Hanto DW; Mohanakumar T
    Transplant Proc; 1991 Feb; 23(1 Pt 1):409-10. PubMed ID: 1990569
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic transfusion in hemodialyzed patients. A prospective study: kinetics of immunization against T and B lymphocytes and incidence of graft survival.
    Bignon JD; Soulillou JP; Peyrat MA; Le Forestier M; Guimbretiere J; Guenel J
    Transplant Proc; 1981 Mar; 13(1 Pt 1):184-9. PubMed ID: 7022819
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of anti-HLA antibody using small-dose single-donor blood transfusion.
    Ettenger R; Cho S; Marik J; von Lilien T; Fine RN
    Transplant Proc; 1987 Feb; 19(1 Pt 1):740-2. PubMed ID: 3274859
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of human recombinant erythropoietin therapy on panel reactive antibodies in chronic dialysis patients.
    Friedlaender MM; Azem O; Rubinger D; Brautbar C
    Isr J Med Sci; 1996 Sep; 32(9):730-6. PubMed ID: 8865827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [T- and B-lymphocyte count in patients waiting for kidney transplantation and retransplantation].
    Petrova IV; Baeva LB; Vasil'eva LL; Naumtseva SI; Levitskiĭ ER
    Probl Gematol Pereliv Krovi; 1978 Dec; (12):14-6. PubMed ID: 370814
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood transfusions under cyclosporine coverage before renal transplantation in children.
    Niaudet P; Bouvattier C; Gouda H; Mattlinger B; Caillat-Zucman S; Gagnadoux MF; Broyer M; Jean G
    Transplant Proc; 1995 Apr; 27(2):1723-4. PubMed ID: 7725470
    [No Abstract]   [Full Text] [Related]  

  • 8. Allogeneic sensitization alters T-cell reactivity to extracellular matrix proteins in prospective transplant recipients.
    Podobińska I; Stepień-Sopniewska B; Mrowiec T; Korczak-Kowalska G; Wierzbicki P; Lis K; Górski A
    Transplant Proc; 1995 Feb; 27(1):494. PubMed ID: 7879074
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistance to rHuEpo and kidney graft rejection.
    Page B; Zingraff J
    Nephrol Dial Transplant; 1994; 9(11):1696. PubMed ID: 7870369
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiidiotypic antibody activity in patients receiving donor specific transfusions and cyclosporine A.
    Stewart KN; Power DA; Hills AN; Catto GR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2262-3. PubMed ID: 3079078
    [No Abstract]   [Full Text] [Related]  

  • 11. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythropoietin and plasmapheresis in the highly sensitized patient: results of a pilot study.
    Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Yasin I; Pingle A
    Transplant Proc; 1994 Aug; 26(4):1855. PubMed ID: 8066603
    [No Abstract]   [Full Text] [Related]  

  • 13. [T- and B-lymphocyte reactivity in sepsis in urological patients and cadaver kidney allograft recipients].
    Dzerzhinskaia II
    Sov Med; 1978 Oct; (10):42-4. PubMed ID: 362553
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement in anaemia following renal transplantation but not after erythropoietin therapy in a patient with sickle-cell disease.
    Thuraisingham RC; Roger SD; Macdougall IC; Cavill I; Stephens AD; Baker LR; Raine AE
    Nephrol Dial Transplant; 1993; 8(4):371-2. PubMed ID: 8390015
    [No Abstract]   [Full Text] [Related]  

  • 15. Towards long-term graft survival in renal transplantation: the role of erythropoietin.
    Moore R
    Nephrol Dial Transplant; 1995; 10 Suppl 1():20-2. PubMed ID: 7617275
    [No Abstract]   [Full Text] [Related]  

  • 16. Recombinant human erythropoietin and renal transplantation. The Canadian Erythropoietin Study Group.
    Keown PA
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):52-8. PubMed ID: 2192417
    [No Abstract]   [Full Text] [Related]  

  • 17. The positive cross-match: antibody class and specificity correlate with graft outcome.
    Chapman JR; Taylor CJ; Ting A; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):725-6. PubMed ID: 3274853
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-idiotypic autoantibodies after donor-specific blood transfusions.
    Toma H; Hayasaka Y; Yasuo M; Takahashi K; Teraoka S; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 1):755-7. PubMed ID: 3274864
    [No Abstract]   [Full Text] [Related]  

  • 19. A first report: living related kidney transplantation on a patient with Bartter's syndrome.
    Takahashi M; Yanagida N; Okano M; Ishizaki A; Meguro J; Kukita K; Tamaki T; Yonekawa M; Kawamura A; Yokoyama T
    Transplant Proc; 1996 Jun; 28(3):1588. PubMed ID: 8658796
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversing the anemia of renal failure.
    Hatch FE
    Hosp Pract (Off Ed); 1990 Feb; 25(2A):25-34. PubMed ID: 2105980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.